DarioHealth Announces Participation in the Cowen 41st Annual Healthcare Conference

Rhea-AI Summary

DarioHealth Corp. (Nasdaq: DRIO) has announced its participation in the Cowen 41st Annual Health Care Conference, set to take place virtually from March 1-4, 2021. CEO Erez Raphael and President Rick Anderson will present on March 1st at 11:00 a.m. ET. DarioHealth is a leader in digital therapeutics, offering AI-powered solutions aimed at managing chronic conditions like diabetes and hypertension. The company emphasizes personalized experiences and clinically proven tools to foster health improvements.

Positive

• Participation in the Cowen 41st Annual Health Care Conference may boost visibility and investor interest.
• DarioHealth's digital therapeutic solutions are among the highest-rated in diabetes and hypertension management.

Negative

• None.

NEW YORK, Feb. 23, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming Cowen 41^st Annual Health Care Conference, a virtual event taking place March 1-4, 2021.

Dario's CEO, Erez Raphael and Rick Anderson, President and General Manager for North America are scheduled to present in a virtual setting on Monday, March 1st, 2021 at 11:00 a.m. ET. Interested parties can access the live and archived webcast at www.dariohealth.investorroom.com.

About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario's next-generation, AI-powered, digital therapeutic solutions support more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users' health. Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.

DarioHealth Corporate Contact:
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220

Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390

Media Contact:
Natalie Joslin
dariohealth@mergeworld.com
+1 301-233-7907

View original content:http://www.prnewswire.com/news-releases/dariohealth-announces-participation-in-the-cowen-41st-annual-healthcare-conference-301233466.html

SOURCE DarioHealth Corp.

FAQ

What is the date of DarioHealth's presentation at the Cowen Annual Health Care Conference?

DarioHealth's presentation will take place on March 1, 2021, at 11:00 a.m. ET.

Who will represent DarioHealth at the Cowen Conference?

Erez Raphael, CEO, and Rick Anderson, President and General Manager for North America, will represent DarioHealth.

How can I access the webcast of DarioHealth's presentation?

The webcast can be accessed live and in archived form at www.dariohealth.investorroom.com.

What type of solutions does DarioHealth provide?

DarioHealth offers AI-powered digital therapeutic solutions for managing chronic conditions such as diabetes and hypertension.